Skip to main content
Table of Contents
Print

Are there specific health conditions that contraindicate cannabis use in trigeminal neuralgia? 

Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

While cannabis is increasingly explored for managing trigeminal neuralgia, it is not universally safe. Certain cannabis contraindications make its use risky, especially for patients with specific underlying health conditions. Recognising these risks is vital before beginning therapy. 

Conditions to Consider 

Understanding cannabis contraindications allows patients and clinicians to make more informed decisions. 

Cardiac Conditions 

Patients with heart disease or high blood pressure should exercise caution. Cannabis may worsen cardiovascular strain, making cardiac conditions a key concern. 

Psychiatric Disorders 

Cannabis can sometimes heighten anxiety, paranoia, or mood fluctuations. For individuals with pre-existing psychiatric disorders, these effects may interfere with stability and treatment. 

Immunosuppression 

Cannabis can interact with immune system regulation. For patients undergoing therapies that cause immunosuppression, careful monitoring or avoidance may be necessary. 

Medication Conflicts 

Beyond direct health issues, cannabis may interact with prescribed drugs. Patients should discuss their situation with healthcare professionals to avoid adverse outcomes. 

Clinician Guidance 

Open conversations with clinicians help identify risks, tailor treatment, and ensure safe use despite possible cannabis contraindications

Patients with trigeminal neuralgia should carefully consider cannabis contraindications before beginning therapy. Special attention is needed for those with cardiac conditionspsychiatric disorders, or immunosuppression. With proper medical advice, cannabis may still be an option for some, but awareness of risks is essential. 

If you’re exploring cannabis treatment options for trigeminal neuralgia, visit providers like LeafEase for personalised consultations and guidance tailored to your needs. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and trigeminal neuralgia.

Julia Sutton, MSc
Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Clarissa Morton, PharmD
Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy. 

Categories